NEW
Stock Screener with Intrinsic Value
Vertex Pharmaceuticals Incorporated (VRTX)
Last Price$409.9(0.5%)
Market Cap$105.0B
9.9%
Peers median - 18.8%
(11.0%)
Peers median - 12.6%
10.9%
Peers median - 7.9%
(16.5%)
Peers median - (18.0%)
Competing with VRTX
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
Compare VRTX Valuation Multiples with Peers
Crunching data... Almost there!
Compare VRTX Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Vertex Pharmaceuticals Incorporated (VRTX) revenue growth compare to peers and the industry?
Vertex Pharmaceuticals Incorporated (VRTX) revenue growth is 9.9%, compared to the peers' median of 18.8%.
2. How does Vertex Pharmaceuticals Incorporated (VRTX) Free Cash Flow (FCF) margin compare to peers and the industry?
Vertex Pharmaceuticals Incorporated (VRTX) FCF margin is (11.0%), compared to the peers' median of 12.6%.
3. How does Vertex Pharmaceuticals Incorporated (VRTX) Total Debt to Equity ratio compare to peers and the industry?
Vertex Pharmaceuticals Incorporated (VRTX) Total Debt to Equity ratio is 10.9%, compared to the peers' median of 7.9%.
4. How does Vertex Pharmaceuticals Incorporated (VRTX) ROIC (Return on Invested Capital) compare to peers and the industry?
Vertex Pharmaceuticals Incorporated (VRTX) ROIC is (16.5%), compared to the peers' median of (18.0%).